DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
12.01
26
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gross Margin
DaShenLin Pharmaceutical Group Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | CN |
| Market Cap | 17.4B CNY |
| Gross Margin |
34%
|
| Country | ZA |
| Market Cap | 98.2B Zac |
| Gross Margin |
23%
|
| Country | ZA |
| Market Cap | 31.9B Zac |
| Gross Margin |
23%
|
| Country | BR |
| Market Cap | 44.6B BRL |
| Gross Margin |
30%
|
| Country | US |
| Market Cap | 7.5B USD |
| Gross Margin |
18%
|
| Country | JP |
| Market Cap | 845.2B JPY |
| Gross Margin |
35%
|
| Country | SA |
| Market Cap | 16.8B SAR |
| Gross Margin |
39%
|
| Country | CN |
| Market Cap | 27.3B CNY |
| Gross Margin |
38%
|
| Country | MX |
| Market Cap | 70.6B MXN |
| Gross Margin |
23%
|
| Country | JP |
| Market Cap | 547.7B JPY |
| Gross Margin |
20%
|
| Country | NL |
| Market Cap | 2.9B EUR |
| Gross Margin |
23%
|
DaShenLin Pharmaceutical Group Co Ltd
Glance View
DaShenLin Pharmaceutical Group Co., Ltd. engages in the retail and wholesale of pharmaceutical products. The company is headquartered in Guangzhou, Guangdong and currently employs 38,353 full-time employees. The company went IPO on 2017-07-31. The firm's primary business includes direct sales and retailing of Chinese and Western medicine, ginseng nourishing herbs and Chinese medicine pieces, health products, medical apparatus and instruments and other commodities. The firm mainly conducts its business within domestic market.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on DaShenLin Pharmaceutical Group Co Ltd's most recent financial statements, the company has Gross Margin of 34.3%.
You don't have any saved screeners yet
